Advertisement

Topics

Increasing Throughput and Reproducibility of mAb Therapeutic Candidate Screening

10:54 EDT 8 Aug 2017 | Drug Discovery Development

The purification process to identify mAbs with ideal specificity, affinity, and binding kinetics requires hundreds of candidates to be purified and screened in downstream functional assays. Achieving the ideal purity and state can create a bottleneck in the screening process.
Contributed Author: 
Candice Cox, Global Product Manager, Bio-Rad Laboratories
Topics: 

Original Article: Increasing Throughput and Reproducibility of mAb Therapeutic Candidate Screening

NEXT ARTICLE

More From BioPortfolio on "Increasing Throughput and Reproducibility of mAb Therapeutic Candidate Screening"

Quick Search
Advertisement
 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...